Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 167

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Early-Pregnancy Plasma Concentrations of Perfluoroalkyl Substances and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics?

Open access
Sagiv, Sharon K, Rifas-Shiman, Sheryl L, Fleisch, Abby F, Webster, Thomas F, Calafat, Antonia M, Ye, Xiaoyun, Gillman, Matthew W, Oken, Emily · 2018 · American Journal of Epidemiology

Abstract

Associations of prenatal exposure to perfluoroalkyl substances (PFAS), ubiquitous chemicals used in stain- and water-resistant products, with adverse birth outcomes may be confounded by pregnancy hemodynamics. We measured plasma concentrations of 4 PFAS in early pregnancy (median length of gestation, 9 weeks) among 1,645 women in Project Viva, a study of a birth cohort recruited during 1999-2002 in eastern Massachusetts. We fitted multivariable models to estimate associations of PFAS with birth weight-for-gestational age z score and length of gestation, adjusting for sociodemographic confounders and 2 hemodynamic markers: 1) plasma albumin concentration, a measure of plasma volume expansion, and 2) plasma creatinine concentration, used to estimate glomerular filtration rate. Perfluorooctane sulfonate (PFOS) and perfluorononanoate (PFNA) were weakly inversely associated with birth weight-for-gestational age z scores (adjusted β = -0.04 (95% confidence interval (CI): -0.08, 0.01) and adjusted β = -0.06 (95% CI: -0.11, -0.01) per interquartile-range increase, respectively). PFOS and PFNA were also associated with higher odds of preterm birth (e.g., for highest PFOS quartile vs. lowest, adjusted odds ratio = 2.4, 95% CI: 1.3, 4.4). Adjusting for markers of pregnancy hemodynamics (glomerular filtration rate and plasma albumin), to the extent that they accurately reflect underlying pregnancy physiology, did not materially affect associations. These results suggest that pregnancy hemodynamics may not confound associations with birth outcomes when PFAS are measured early in pregnancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/aje/kwx332

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 38

  1. Calafat, 2007, Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES), Environ Sci Technol, 41, 2237, 10.1021/es062686m · DOI · Paper page
  2. Olsen, 2009, Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives, Reprod Toxicol, 27, 212, 10.1016/j.reprotox.2009.02.001 · DOI · Paper page
  3. Fei, 2007, Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort, Environ Health Perspect, 115, 1677, 10.1289/ehp.10506 · DOI · Paper page
  4. Apelberg, 2007, Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth, Environ Health Perspect, 115, 1670, 10.1289/ehp.10334 · DOI · Paper page
  5. Maisonet, 2012, Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls, Environ Health Perspect, 120, 1432, 10.1289/ehp.1003096 · DOI · Paper page
  6. Chen, 2012, Perfluorinated compounds in umbilical cord blood and adverse birth outcomes, PLoS One, 7, e42474, 10.1371/journal.pone.0042474 · DOI · Paper page
  7. Wu, 2012, Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes, Environ Int, 48, 1, 10.1016/j.envint.2012.06.018 · DOI
  8. Stein, 2009, Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome, Am J Epidemiol, 170, 837, 10.1093/aje/kwp212 · DOI · Paper page
  9. Washino, 2009, Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth, Environ Health Perspect, 117, 660, 10.1289/ehp.11681 · DOI · Paper page
  10. Wang, 2016, Prenatal exposure to perfluorocarboxylic acids (PFCAs) and fetal and postnatal growth in the Taiwan Maternal and Infant Cohort Study, Environ Health Perspect, 124, 1794, 10.1289/ehp.1509998 · DOI
  11. de Cock, 2016, Prenatal exposure to endocrine disrupting chemicals and birth weight—a prospective cohort study, J Environ Sci Health A Tox Hazard Subst Environ Eng, 51, 178, 10.1080/10934529.2015.1087753 · DOI
  12. Bach, 2016, Perfluoroalkyl acids in maternal serum and indices of fetal growth: the Aarhus Birth Cohort, Environ Health Perspect, 124, 848, 10.1289/ehp.1510046 · DOI
  13. Lenters, 2016, Prenatal phthalate, perfluoroalkyl acid, and organochlorine exposures and term birth weight in three birth cohorts: multi-pollutant models based on elastic net regression, Environ Health Perspect, 124, 365, 10.1289/ehp.1408933 · DOI · Paper page
  14. Kishi, 2015, The association of prenatal exposure to perfluorinated chemicals with maternal essential and long-chain polyunsaturated fatty acids during pregnancy and the birth weight of their offspring: the Hokkaido Study, Environ Health Perspect, 123, 1038, 10.1289/ehp.1408834 · DOI
  15. Darrow, 2013, Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the mid-Ohio Valley, 2005–2010, Environ Health Perspect, 121, 1207, 10.1289/ehp.1206372 · DOI · Paper page
  16. Whitworth, 2012, Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study, Am J Epidemiol, 175, 1209, 10.1093/aje/kwr459 · DOI
  17. Savitz, 2012, Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community, Epidemiology, 23, 386, 10.1097/EDE.0b013e31824cb93b · DOI · Paper page
  18. Savitz, 2012, Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley, Environ Health Perspect, 120, 1201, 10.1289/ehp.1104752 · DOI
  19. Nolan, 2009, The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water, Reprod Toxicol, 27, 231, 10.1016/j.reprotox.2008.11.001 · DOI
  20. Lee, 2016, Association between perfluorinated compound concentrations in cord serum and birth weight using multiple regression models, Reprod Toxicol, 59, 53, 10.1016/j.reprotox.2015.10.020 · DOI
  21. Savitz, 2007, Biomarkers of perfluorinated chemicals and birth weight, Environ Health Perspect, 115, A528, 10.1289/ehp.10923 · DOI
  22. Savitz, 2014, Invited commentary: interpreting associations between exposure biomarkers and pregnancy outcome, Am J Epidemiol, 179, 545, 10.1093/aje/kwt314 · DOI
  23. Chapman, 1998, Temporal relationships between hormonal and hemodynamic changes in early human pregnancy, Kidney Int, 54, 2056, 10.1046/j.1523-1755.1998.00217.x · DOI · Paper page
  24. Morken, 2014, Maternal glomerular filtration rate in pregnancy and fetal size, PLoS One, 9, e101897, 10.1371/journal.pone.0101897 · DOI
  25. Oken, 2015, Cohort profile: Project Viva, Int J Epidemiol, 44, 37, 10.1093/ije/dyu008 · DOI · Paper page
  26. Kato, 2011, Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals, J Chromatogr A, 1218, 2133, 10.1016/j.chroma.2010.10.051 · DOI · Paper page
  27. Kuklenyik, 2005, Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction, Anal Chem, 77, 6085, 10.1021/ac050671l · DOI · Paper page
  28. Hornung, 1990, Estimation of average concentration in the presence of nondetectable values, Appl Occup Environ Hyg, 5, 46, 10.1080/1047322X.1990.10389587 · DOI · Paper page
  29. Sagiv, 2015, Sociodemographic and perinatal predictors of early pregnancy per- and polyfluoroalkyl substance (PFAS) concentrations, Environ Sci Technol, 49, 11849, 10.1021/acs.est.5b02489 · DOI · Paper page
  30. Oken, 2003, A nearly continuous measure of birth weight for gestational age using a United States national reference, BMC Pediatr, 3, 6, 10.1186/1471-2431-3-6 · DOI · Paper page
  31. Phillips, 2011, Previous breastfeeding practices and duration of exclusive breastfeeding in the United States, Matern Child Health J, 15, 1210, 10.1007/s10995-010-0694-4 · doi:10.1007/s10995-010-0694-4
  32. D’eon, 2010, Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy, Environ Toxicol Chem, 29, 1678, 10.1002/etc.204 · DOI
  33. DeWitt, 2015, Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances, 10.1007/978-3-319-15518-0 · DOI · Paper page
  34. Vanden Heuvel, 2006, Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α, -β, and -γ, liver X receptor-β, and retinoid X receptor-α, Toxicol Sci, 92, 476, 10.1093/toxsci/kfl014 · DOI · Paper page
  35. DeWitt, 2009, Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha, Crit Rev Toxicol, 39, 76, 10.1080/10408440802209804 · DOI · Paper page
  36. Verner, 2015, Associations of perfluoroalkyl substances (PFAS) with lower birth weight: an evaluation of potential confounding by glomerular filtration rate using a physiologically based pharmacokinetic model (PBPK), Environ Health Perspect, 123, 1317, 10.1289/ehp.1408837 · DOI · Paper page
  37. Shi, 2017, Occurrence of perfluoroalkyl substances in cord serum and association with growth indicators in newborns from Beijing, Chemosphere, 169, 396, 10.1016/j.chemosphere.2016.11.050 · DOI
  38. Fromme, 2010, Pre- and postnatal exposure to perfluorinated compounds (PFCs), Environ Sci Technol, 44, 7123, 10.1021/es101184f · DOI · Paper page

Cited by

See all 167

Metadata

Authors
Sagiv, S. K., Rifas-Shiman, S. L., Fleisch, A. F., Webster, T. F., Calafat, A. M., Ye, X., Gillman, M. W., & Oken, E.
Venue
American Journal of Epidemiology
Published
2017-11-16
Volume
187
Issue
4
Pages
793-802
ISSN
  • 0002-9262 (ISSN-L)
  • 1476-6256
OpenAlex
W2791210587
Cited by
167
References
12
FWCI
5.86
Type
journal article
Language
en
Open access
bronze
Funders
National Institutes of Health (R01ES021447, R01HD34568, K23ES024803)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early-Pregnancy Plasma Concentrations of Perfluoroalkyl Substances and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics? https://app.cochat.ai/papers/10.1093/aje/kwx332
The paper
Sagiv, S. K., Rifas-Shiman, S. L., Fleisch, A. F., Webster, T. F., Calafat, A. M., Ye, X., Gillman, M. W., & Oken, E. (2018). Early-Pregnancy Plasma Concentrations of Perfluoroalkyl Substances and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics? American Journal of Epidemiology. https://doi.org/10.1093/aje/kwx332

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.